back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-05-15 11:56 Tx date 2023-05-12 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
56 - Grant of rights
|
$44,998
+9,259 vol $4.86 each |
23,189 | |
| Filed 2022-05-16 10:05 Tx date 2022-05-13 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
56 - Grant of rights
|
$44,996
+8,620 vol $5.22 each |
13,930 | |
| Filed 2022-04-08 10:54 Tx date 2022-04-06 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,120
+400 vol $5.30 each |
11,800 | |
| Filed 2022-04-08 10:54 Tx date 2022-04-06 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,620
+2,000 vol $5.31 each |
11,400 | |
| Filed 2022-04-08 10:54 Tx date 2022-04-06 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,942
+1,500 vol $5.29 each |
9,400 | |
| Filed 2022-04-08 10:53 Tx date 2022-04-06 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,120
+400 vol $5.30 each |
7,900 | |
| Filed 2022-04-08 10:53 Tx date 2022-04-06 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$531.00
+100 vol $5.31 each |
7,500 | |
| Filed 2022-04-08 10:53 Tx date 2022-04-06 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,600
+2,000 vol $5.30 each |
7,400 | |
| Filed 2022-04-08 10:52 Tx date 2022-04-06 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,161
+600 vol $5.27 each |
5,400 | |
| Filed 2021-09-20 11:38 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$526.00
+100 vol $5.26 each |
4,800 | |
| Filed 2021-09-20 11:37 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$518.00
+100 vol $5.18 each |
4,700 | |
| Filed 2021-09-20 11:37 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,036
+200 vol $5.18 each |
4,600 | |
| Filed 2021-09-20 11:36 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$518.00
+100 vol $5.18 each |
4,400 | |
| Filed 2021-09-20 11:36 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,554
+300 vol $5.18 each |
4,300 | |
| Filed 2021-09-20 11:36 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$518.00
+100 vol $5.18 each |
4,000 | |
| Filed 2021-09-20 11:36 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,036
+200 vol $5.18 each |
3,900 | |
| Filed 2021-09-20 11:35 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,036
+200 vol $5.18 each |
3,700 | |
| Filed 2021-09-20 11:34 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,036
+200 vol $5.18 each |
3,500 | |
| Filed 2021-09-20 11:34 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$518.00
+100 vol $5.18 each |
3,300 | |
| Filed 2021-09-20 11:34 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,036
+200 vol $5.18 each |
3,200 | |
| Filed 2021-09-20 11:33 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,360
+2,000 vol $5.18 each |
3,000 | |
| Filed 2021-09-20 11:33 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,136
+800 vol $5.17 each |
1,000 | |
| Filed 2021-09-20 11:33 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$517.00
+100 vol $5.17 each |
200 | |
| Filed 2021-09-20 11:32 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$517.00
+100 vol $5.17 each |
100 | |
| Filed 2021-09-20 11:31 Tx date 2020-06-25 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-24 15:40 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
56 - Grant of rights
|
$30,001
+5,310 vol $5.65 each |
5,310 | |
| Filed 2021-05-20 13:15 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$30,001
+5,310 vol $5.65 each |
||
| Filed 2021-05-20 11:31 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$30,001
+5,310 vol $5.65 each |
||
| Filed 2021-05-20 13:15 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$30,001
+5,310 vol $5.65 each |
5,310 | |
| Filed 2021-05-20 13:14 Tx date 2020-06-25 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-20 11:31 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$30,001
+5,310 vol $5.65 each |
5,310 | |
| Filed 2021-05-20 11:31 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$30,001
+5,310 vol $5.65 each |
||
| Filed 2021-05-20 11:31 Tx date 2020-06-25 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-20 11:31 Tx date 2020-06-25 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-03 16:14 Tx date 2020-07-01 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
20,000 | |
| Filed 2020-07-03 16:13 Tx date 2020-06-25 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|